B2M and early-onset autosomal dominant Alzheimer disease: Within the central nervous system, B2M is involved in the pathogenesis of diverse cerebral disorders, such as encephalopathy (Carreras et al. 2022), Alzheimer’s disease (Zhao et al. 2023), and cerebral tumors (Li et al. 2022).